taitunic News World

  Defence counsel’s Ill-health stalls ex-Gov Aliyu’s trial for alleged N2b fraud November 23, 2020 By  Ripples Nigeria Absence of one of the defence counsels on Monday stalled the alleged N2billion trial of the former Niger State Governor, Babangida Aliyu, at the Federal High Court, Minna, on Monday. Justice A.B. Aliyu was forced to adjourn the case till January 18 and 19 next year after Mamman Mike Osman, the counsel to the former governor’s chief of staff, Umar Gado Nasko, was declared ill. However, the prosecution counsel, G.O Adebola, rejected the application for the adjournment of the case on health ground, saying he went to a great length to bring witnesses from Abuja and Port Harcourt and other places to the court. However, the ex-governor’s counsel, Musa Sulaiman, supported the application for adjournment of the case. READ ALSO:  MONEY LAUNDERING: Court adjourns retrial of ex-Gov Babangida Aliyu The counsel said he was not aware of any human being that is immune t...

 The Comparative Cost advantage. It may sound common as usual, but we have to start from the root. What is Comparative Cost advantage?  Comparative Cost advantage theory states that, a country will specialize in production of such good where she has the greatest comparative    advantage or least comparative disadvantage. Jacob intensify his efforts in animal rearing and it paid off, have u ever look deep and check for your best area where you have greatest 0comparative advantage over other in life ? David start by keeping the sheep and later reigned as king. Where you are now, you have that advantage where ur opportunity cost is very low and the paid off is high just dog deep and exploit the resources God bless you with.... Enjoy your day till we meet again. 

  Covid-19: Oxford University vaccine is highly effective By James Gallagher Health and science correspondent Published 3 hours ago Related Topics Coronavirus pandemic IMAGE COPYRIGHT OXFORD UNIVERSITY/JOHN CAIRNS image caption The Oxford/AstraZeneca vaccine is currently in the final stages of testing The coronavirus vaccine developed by the University of Oxford is highly effective at stopping people developing Covid-19 symptoms, a large trial shows. Interim data suggests 70% protection, but the researchers say the figure may be as high as 90% by tweaking the dose. The results will be seen as a triumph, but come after Pfizer and Moderna vaccines showed 95% protection. However, the Oxford jab is far cheaper, and is easier to store and get to every corner of the world than the other two. So the vaccine will play a significant role in tackling the pandemic, if it is approved for use by regulators. "The announcement today takes us another step closer to the time when we can use vaccin...